37 peer-reviewed studies · Evidence score: 8.5/10
Ho E et al. • Annual review of nutrition (2025)
Integrating cruciferous vegetables and their bioactive compounds in light of an individual's microbiome profile as a complementary approach alongside standard treatments is a promising strategy in breast cancer care.
Amarakoon D et al. • Annual review of food science and technology (2023)
This article reviews current knowledge of the occurrence of I3C in nature and foods, along with the beneficial effects of I3C and DIM concerning prevention and treatment of human chronic diseases, focusing on preclinical studies and their mechanisms of action at cellular and molecular levels.
Singla RK et al. • Critical reviews in food science and nutrition (2023)
The future perspectives on the translation of these findings to the personalized treatment of BC are provided and discussed.
Tian C et al. • Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (2024)
Mechanistically, I3C and DIM modulate various pathophysiological processes, including cell proliferation, apoptosis, oxidative stress, and lipogenesis.
Anchimowicz J et al. • Postepy biochemii (2023)
DNA methylation, histone acetylation and microRNAs expression in cancer treatment.
Chang Y et al. • Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (2021)
Recently, a growing body of studies has indicated that phytochemicals derived from natural products are potent regulators of Th17/Treg, and exert preferable protective benefits against colonic infl...
Kim SM • International journal of molecular sciences (2016)
Therefore, this review provides a comprehensive understanding of the preventive and therapeutic properties of DIM in addition to its different perspective on the safety of DIM in clinical applications for the treatment of gastrointestinal cancers.
Li Y et al. • Medical principles and practice : international journal of the Kuwait University, Health Science Centre (2016)
This systematic-review examined the effects of DIM.
Bock KW • Biochemical pharmacology (2018)
Extrapolation from animals to humans is difficult due to marked species differences and dependence of AHR function on the cellular context.
Capuano E et al. • Current pharmaceutical design (2017)
It appears that certain BPs may protect against and may even represent a therapeutic strategy against several forms of cancer.
Bock KW • Biochemical pharmacology (2017)
Comparison of AHR functions with those of PXR and its target enzyme CYP3A4 may be helpful to emphasize AHR functions in specialized cells: PXR is known to be mainly involved in regulation of system...
Licznerska B et al. • Advances in experimental medicine and biology (2016)
This chapter summarizes the current experimental data on the I3C and DIM activity and the results of clinical studies indicating their role in prevention of chronic diseases.
Wang SQ et al. • Current drug metabolism (2016)
Indoles, especially I3C and DIM as phytochemicals, exert anti-fibrosis, anti-tumor, anti-oxidant, immunomodulatory, detoxification and anti-inflammation effects on hepatic protection through pleiotropic mechanism.
Thomson CA et al. • Nutrition reviews (2016)
For Permissions, please e-mail: journals.permissions@oup.com.
Li Y et al. • Cancer metastasis reviews (2014)
Such strategy could become a promising newer approach for the treatment of metastatic PCa with better treatment outcome by improving overall survival.
Li Y et al. • Antioxidants & redox signaling (2013)
However, more clinical trials are needed to evaluate the effects of isoflavone and DIM for the prevention of cancer development and also for the treatment of cancer either alone or in combination with conventional cancer therapeutics.
Kandala PK et al. • Current drug targets (2012)
Together, our pre-clinical studies demonstrate that DIM has activity against ovarian cancer and hence should be further investigated in clinical setting to exploit its therapeutic potential.
Sarkar FH et al. • Cellular signalling (2009)
Therefore, non-toxic "natural agents" harvested from the bounties of nature could be useful either alone or in combination with conventional therapeutics for the prevention of tumor progression and/or treatment of human malignancies.
Aggarwal BB et al. • Cell cycle (Georgetown, Tex.) (2005)
Initial clinical trials in women have shown that I3C is a promising agent against breast and cervical cancers.
Acharya A et al. • Recent patents on food, nutrition & agriculture (2010)
This review is focused on the patents generated on the effects of I3C, DIM and selected phytochemicals of cardamom on carcinogenesis.